Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

133 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2024.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 178,106,548 shares of 266,212,950 outstanding shares and own 67% of the company stock.
Largest 10 shareholders include Syncona Portfolio Ltd (21,346,829 shares), Blackstone Inc. (20,485,611 shares), WELLINGTON MANAGEMENT GROUP LLP (17,889,834 shares), Deep Track Capital, LP (15,272,172 shares), Avoro Capital Advisors LLC (12,345,678 shares), FMR LLC (12,295,167 shares), TFG Asset Management GP Ltd (8,000,000 shares), ARMISTICE CAPITAL, LLC (6,250,000 shares), Frazier Life Sciences Management, L.P. (4,623,324 shares), and BlackRock Inc. (4,436,102 shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.